Perioperative Amikacin Dose in 10kg Child
For a 10 kg child requiring perioperative amikacin, administer 150 mg (15 mg/kg) as a single intravenous dose.
Dosing Rationale
The FDA-approved dosing for children with normal renal function is 15 mg/kg/day divided into 2-3 equal doses (7.5 mg/kg q12h or 5 mg/kg q8h), with a maximum daily dose not exceeding 15 mg/kg/day 1. For perioperative prophylaxis or single-dose therapy, the full daily dose of 15 mg/kg can be administered as a single dose.
Multiple guidelines consistently support the 15-30 mg/kg range for pediatric dosing 2, 3, 4, 3. The lower end of this range (15 mg/kg) is appropriate for:
- Initial perioperative dosing
- Children with normal renal function
- Single-dose or short-term therapy
For a 10 kg child: 15 mg/kg × 10 kg = 150 mg
Administration Details
- Route: Intravenous infusion over 30-60 minutes 1
- Timing: Administer as a single perioperative dose
- Preparation: Dilute in 50-100 mL of 0.9% sodium chloride or 5% dextrose
When to Consider Higher Dosing (20-30 mg/kg)
The upper dosing range may be warranted for:
- Severe gram-negative infections requiring higher peak concentrations 5
- Loading dose scenarios where rapid therapeutic levels are needed 6
- Pseudomonas or resistant organisms with higher MICs 7
However, for routine perioperative use, 15 mg/kg is the standard and FDA-recommended dose.
Critical Safety Considerations
Renal Function Monitoring
- Baseline: Obtain serum creatinine before administration 1
- Contraindication: Do not use if significant renal impairment exists without dose adjustment
- Post-operative: Monitor renal function if multiple doses are required
Ototoxicity Risk
- Baseline audiometry is recommended for prolonged therapy (>7-10 days) but not necessary for single perioperative doses 3, 4
- Risk increases with: concurrent diuretics, prolonged therapy, cumulative doses >100-120g 3
- Amikacin causes primarily auditory toxicity (less vestibular dysfunction than streptomycin) 3
Therapeutic Drug Monitoring (TDM)
For single perioperative doses, TDM is not routinely necessary. However, if multiple doses are required:
- Peak target: 30-40 mg/L (measured 30-90 minutes post-infusion) 1
- Trough target: <5-10 mg/L (measured just before next dose) 2, 1
- Peak concentrations >35 mcg/mL and trough >10 mcg/mL should be avoided 1
Common Pitfalls to Avoid
- Underdosing: Using 7.5 mg/kg as a single dose (this is the q12h divided dose, not the total daily dose)
- Overdosing: Exceeding 15 mg/kg/day total without clear indication for severe infection
- Rapid infusion: Administering as IV push rather than 30-60 minute infusion increases toxicity risk
- Ignoring renal function: Failing to assess baseline renal function before administration
- Concurrent nephrotoxins: Particular caution with vancomycin co-administration, which significantly increases nephrotoxicity risk 8